The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
Open accessAbstract
BACKGROUND: Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugsNeedle syringe programmes (NSP) and opioid substitution therapy (OST) are the primary interventions to reduce hepatitis C (HCV) transmission in people who inject drugs. There is good evidence for the effectiveness of NSP and OST in reducing injecting risk behaviour and increasing evidence for the effectiveness of OST and NSP in reducing HIV acquisition risk, but the evidence on the effectiveness of NSP and OST for preventing HCV acquisition is weak. OBJECTIVES: To assess the effects of needle syringe programmes and opioid substitution therapy, alone or in combination, for preventing acquisition of HCV in people who inject drugs. SEARCH METHODS: We searched the Cochrane Drug and Alcohol Register, CENTRAL, the Cochrane Database of Systematic Reviews (CDSR), the Database of Abstracts of Reviews of Effects (DARE), the Health Technology Assessment Database (HTA), the NHS Economic Evaluation Database (NHSEED), MEDLINE, Embase, PsycINFO, Global Health, CINAHL, and the Web of Science up to 16 November 2015. We updated this search in March 2017, but we have not incorporated these results into the review yet. Where observational studies did not report any outcome measure, we asked authors to provide unpublished data. We searched publications of key international agencies and conference abstracts. We reviewed reference lists of all included articles and topic-related systematic reviews for eligible papers. SELECTION CRITERIA: We included prospective and retrospective cohort studies, cross-sectional surveys, case-control studies and randomised controlled trials that measured exposure to NSP and/or OST against no intervention or a reduced exposure and reported HCV incidence as an outcome in people who inject drugs. We defined interventions as current OST (within previous 6 months), lifetime use of OST and high NSP coverage (regular attendance at an NSP or all injections covered by a new needle/syringe) or low NSP coverage (irregular attendance at an NSP or less than 100% of injections covered by a new needle/syringe) compared with no intervention or reduced exposure. DATA COLLECTION AND ANALYSIS: We followed the standard Cochrane methodological procedures incorporating new methods for classifying risk of bias for observational studies. We described study methods against the following 'Risk of bias' domains: confounding, selection bias, measurement of interventions, departures from intervention, missing data, measurement of outcomes, selection of reported results; and we assigned a judgment (low, moderate, serious, critical, unclear) for each criterion. MAIN RESULTS: =0%). We found low-quality evidence of the impact of combined high coverage of NSP and OST, from three studies involving 3241 participants, resulting in a 74% reduction in the risk of HCV acquisition (RR 0.26 95% CI 0.07 to 0.89). AUTHORS' CONCLUSIONS: OST is associated with a reduction in the risk of HCV acquisition, which is strengthened in studies that assess the combination of OST and NSP. There was greater heterogeneity between studies and weaker evidence for the impact of NSP on HCV acquisition. High NSP coverage was associated with a reduction in the risk of HCV acquisition in studies in Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61311-2 · Cited by 1,285
Self-citationPlatt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, I., Razavi, H., & Vickerman, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00485-5 · Cited by 731
Self-citationMathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., Myers, B., Ambekar, A., & Strathdee, S. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60232-2 · Cited by 717
Self-citationNeedle exchange is not enough: lessons from the Vancouver injecting drug use study
Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M. L., Montaner, J. S. G., Schechter, M. T., & OʼShaughnessy, M. V. (1997) · AIDS · doi:10.1097/00002030-199708000-00001 · Cited by 661
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
Schünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
HIV and risk environment for injecting drug users: the past, present, and future
Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60743-x · Cited by 559
Thorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60742-8 · Cited by 423
Self-citationMacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012) · BMJ · doi:10.1136/bmj.e5945 · Cited by 410
Self-citationMethadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt243 · Cited by 399
Self-citationWoody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA · doi:10.1001/jama.2008.574 · Cited by 361
Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802001-00004 · Cited by 346
Gibson, D. R., Flynn, N. M., & Perales, D. (2001) · AIDS · doi:10.1097/00002030-200107270-00002 · Cited by 324
The Everyday Violence of Hepatitis C among Young Women Who Inject Drugs in San Francisco
Bourgois, P., Prince, B., & Moss, A. (2004) · Human Organization · doi:10.17730/humo.63.3.h1phxbhrb7m4mlv0 · Cited by 318
Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01912.x · Cited by 316
Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir196 · Cited by 313
Self-citationTurner, K. M. E., Hutchinson, S., Vickerman, P., Hope, V., Craine, N., Palmateer, N., May, M., Taylor, A., De Angelis, D., Cameron, S., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03515.x · Cited by 299
Self-citationOral substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub4 · Cited by 296
Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., Tobler, L., Andrews, W., Avanesyan, L., Cooper, S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605947 · Cited by 285
Syringe Exchange and Risk of Infection with Hepatitis B and C Viruses
Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009792 · Cited by 256
Self-citationPalmateer, N., Kimber, J., Hickman, M., Hutchinson, S., Rhodes, T., & Goldberg, D. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02888.x · Cited by 248
Self-citationHagan, H., Jarlais, D. C., Friedman, S. R., Purchase, D., & Alter, M. J. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.11.1531 · Cited by 246
Self-citationvan Beek, I., Dwyer, R., Dore, G. J., Luo, K., & Kaldor, J. M. (1998) · BMJ · doi:10.1136/bmj.317.7156.433 · Cited by 234
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 222
Self-citationPatrick, D. M., TYNDALL, M. W., Cornelisse, P., Li, K. K., Sherlock, C. H., Rekart, M. L., Strathdee, S. A., Currie, S. L., Schechter, M. T., & O’Shaughnessy, M. V. (2001) · Europe PMC (PubMed Central) · Cited by 203
Tsui, J. I., Evans, J. L., Lum, P. J., Hahn, J. A., & Page, K. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5416 · Cited by 199
A model-based estimate of HIV infectivity via needle sharing.
Kaplan, E. H., & Heimer, R. (1992) · PubMed · Cited by 190
Iversen, J., Page, K., Madden, A., & Maher, L. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000659 · Cited by 189
Self-citationConvergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
Jarlais, D. C. D., Arasteh, K., Perlis, T. E., Hagan, H., Abdul-Quader, A. S., Heckathorn, D. D., McKnight, C. A., Bramson, H., Nemeth, C., Torian, L. V., et al. (2006) · AIDS · doi:10.1097/qad.0b013e3280114a15 · Cited by 184
Self-citationPrevalence, Incidence, and Risk Factors of Hepatitis C Virus Infection among Drug Users in Amsterdam
van den Hoek, J. A. R., van Haastrecht, H. J. A., Goudsmit, J., de Wolf, F., & Coutinho, R. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.4.823 · Cited by 182
Judd, A., Hickman, M., Jones, S., McDonald, T., Parry, J. V., Stimson, G. V., & Hall, A. J. (2005) · BMJ · doi:10.1136/bmj.38286.841227.7c · Cited by 168
Self-citationThe cost-effectiveness of Vancouver's supervised injection facility
Bayoumi, A. M., & Zaric, G. S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080808 · Cited by 167
Vickerman, P. T., Martin, N. K., Turner, K., & Hickman, M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03932.x · Cited by 165
Self-citationDes Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., Smith, L., Wethers, J., Milliken, J., Mildvan, D., et al. (2005) · AIDS · doi:10.1097/01.aids.0000192066.86410.8c · Cited by 163
Self-citationvan Ameijden, E. J. C., Van Den Hoek, J. A. R., Mientjes, G. H. C., & Coutinho, R. A. (1993) · European Journal of Epidemiology · doi:10.1007/bf00146260 · Cited by 161
Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32823f9066 · Cited by 159
Self-citationRapid transmission of hepatitis C virus among young injecting heroin users in Southern China
Garten, R. J. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh019 · Cited by 159
Pouget, E. R., Hagan, H., & Jarlais, D. C. D. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03765.x · Cited by 156
Self-citationHarm reduction interventions, behaviours and associated health outcomes in France, 1996–2003
Emmanuelli, J., & Desenclos, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01271.x · Cited by 155
Hepatitis C virus infection among a cohort of Victorian injecting drug users
Crofts, N., Hopper, J. L., Bowden, D. S., Breschkin, A., LOCARNINI, S. A., & Milner, R. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb137822.x · Cited by 153
The impact of methadone maintenance therapy on heptatis c incidence among illicit drug users.
Nolan, S., Lima, V., Fairbairn, N., Kerr, T., Montaner, J., Grebely, J., & Wood, E. (2014) · Addiction · doi:10.1111/add.12682 · Cited by 144
Gibson, D. R., Flynn, N. M., & McCarthy, J. J. (1999) · AIDS · doi:10.1097/00002030-199910010-00002 · Cited by 141
Dewhurst, J. (2010) · AIDS Care · doi:10.1080/09540120903193757 · Cited by 136
Spencer, J. D., Latt, N. C., Beeby, P. J., Collins, E., Saunders, J. B., McCaughan, G. W., & Cossart, Y. E. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00073.x · Cited by 124
Bluthenthal, R. N., Anderson, R. L., Flynn, N. M., & Kral, A. H. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.035 · Cited by 120
Methadone maintenance and hepatitis C virus infection among injecting drug users
Crofts, N., Nigro, L., Oman, K., Stevenson, E. M., & Sherman, J. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02979.x · Cited by 117
White, B., Dore, G. J., Lloyd, A. R., Rawlinson, W. D., & Maher, L. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.00153 · Cited by 113
Self-citationSullivan, L. E., Chawarski, M., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.12.008 · Cited by 110
Craine, N., Hickman, M., Parry, J., Smith, J., Walker, A., Russell, D., Nix, B., May, M., McDonald, T., & Lyons, M. (2009) · Epidemiology and Infection · doi:10.1017/s095026880900212x · Cited by 108
Self-citationFrequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam
van de Laar, T. J. W., Molenkamp, R., van den Berg, C., Schinkel, J., Beld, M., Prins, M., Coutinho, R. A., & Bruisten, S. M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.027 · Cited by 106
Palmateer, N. E., Taylor, A., Goldberg, D. J., Munro, A., Aitken, C., Shepherd, S. J., McAllister, G., Gunson, R. N., & Hutchinson, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104515 · Cited by 99
Self-citationHigh hepatitis C virus prevalence and incidence among Canadian intravenous drug users
Roy, É., Alary, M., Morissette, C., Leclerc, P., Boudreau, J., Parent, R., Rochefort, J., Claessens, C., & The SurvUDI Working Group (2007) · International Journal of STD & AIDS · doi:10.1258/095646207779949880 · Cited by 92
Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area
Thiede, H., Hagan, H., & Murrill, C. S. (2000) · Journal of Urban Health · doi:10.1007/bf02386744 · Cited by 87
Self-citationMoestrup, T. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540050165875 · Cited by 85
Holtzman, D. J., Barry, V., Ouellet, L. J., Jarlais, D. C. D., Vlahov, D., Golub, E. T., Hudson, S., & Garfein, R. S. (2009) · Preventive Medicine · doi:10.1016/j.ypmed.2009.04.014 · Cited by 81
Lucidarme, D., Bruandet, A., Ilèf, D., Harbonnier, J., Jacob, C., Decoster, A., Delamare, C., Cyran, C., Hoenacker, A. F. V., Fremaux, D., et al. (2004) · Epidemiology and Infection · doi:10.1017/s095026880400247x · Cited by 80
Kwon, J. A., Iversen, J., Maher, L., Law, M. G., & Wilson, D. P. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a2539a · Cited by 78
Self-citationMiller, C. L., Wood, E., Spittal, P. M., Li, K. K., Frankish, J., Braitstein, P. K. A., Montaner, J. S. G., & Schechter, M. T. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200406010-00012 · Cited by 78
Tracy, D., Hahn, J. A., Lewis, C. F., Evans, J. L., Briceño, A., Morris, M. D., Lum, P. J., & Page, K. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004988 · Cited by 78
Ruan, Y., Qin, G., Yin, L., Chen, K., Qian, H., Hao, C., Liang, S., Zhu, J., Xing, H. Q., Hong, K., et al. (2007) · AIDS · doi:10.1097/01.aids.0000304695.54884.4f · Cited by 75
Rezza, G., Sagliocca, L., Zaccarell, M., Nespoli, M., Siconolfi, M., & Baldassarre, C. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609027145 · Cited by 75
Esmaeili, A., Mirzazadeh, A., Carter, G. M., Esmaeili, A., Hajarizadeh, B., Sacks, H. S., & Page, K. A. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12628 · Cited by 70
Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience
Roy, É., Boudreau, J.-F., & Boivin, J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.01.006 · Cited by 69
Wiessing, L. G., Likatavicius, G., Klempová, D., Hedrich, D., Nardone, A., & Griffiths, P. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.141846 · Cited by 67
Burt, R. D., Hagan, H., Garfein, R. S., Sabin, K. M., Weinbaum, C. M., & Thiede, H. (2007) · Journal of Urban Health · doi:10.1007/s11524-007-9178-2 · Cited by 67
Self-citationde Vos, A. S., van der Helm, J. J., Matser, A. A., Prins, M., & Kretzschmar, M. (2013) · Addiction · doi:10.1111/add.12125 · Cited by 64
Frequent Needle Exchange Use and HIV Incidence in Vancouver, Canada
Wood, E., Lloyd‐Smith, E., Li, K. K., Strathdee, S. A., Small, W., TYNDALL, M. W., Montaner, J. S. G., & Kerr, T. H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.030 · Cited by 63
Saraswati, L. R., Sarna, A., Sebastian, M. P., Sharma, V., Madan, I., Thior, I., Pulerwitz, J., & Tun, W. (2015) · BMC Public Health · doi:10.1186/s12889-015-2003-z · Cited by 59
Goldberg, D. J., Cameron, S., & McMenamin, J. (1998) · PubMed · Cited by 59
Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects
Galeazzi, B., Tufano, A., Barbierato, E., & Bortolotti, F. (1995) · Liver International · doi:10.1111/j.1600-0676.1995.tb00672.x · Cited by 57
Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
Heimer, R. (1998) · Europe PMC (PubMed Central) · Cited by 53
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs
Hagan, H., McGough, J. P., Thiede, H., Hopkins, S. G., Weiss, N. S., & Alexander, E. R. (2000) · Journal of Urban Health · doi:10.1007/bf02350966 · Cited by 50
Self-citationGoldberg, D. J. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540152029936 · Cited by 50
Platt, L., Reed, J. R., Minozzi, S., Vickerman, P. T., Hagan, H., French, C. E., Jordan, A. E., Degenhardt, L. J., Hope, V. D., Hutchinson, S. J., et al. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012021 · Cited by 49
Self-citationGrebely, J., Lima, V. D., Marshall, B. D. L., Milloy, M.-J., DeBeck, K., Montaner, J., Simo, A., Krajden, M., Dore, G. J., Kerr, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097726 · Cited by 48
Shannon, K., Kerr, T., Marshall, B. D. L., Li, K. K., Zhang, R., Strathdee, S. A., TYNDALL, M. W., Montaner, J., & Wood, E. (2010) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2009.241 · Cited by 47
Surveillance for newly acquired hepatitis C in Australia
Robotin, M. C., COPLAND, J., Tallis, G. F., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03270.x · Cited by 47
Spittal, P. M., Pearce, M., Chavoshi, N., Christian, W. M., Moniruzzaman, A., Teegee, M. P., & Schechter, M. T. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-632 · Cited by 47
Muga, R., Sanvisens, A., Bolao, F., Tor, J., Santesmases, J., Pujol, R., Tural, C., Langohr, K., Rey‐Joly, C., & Muñoz, Á. (2006) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(06)80005-0 · Cited by 46
Selvey, L. A., Denton, M., & Plant, A. J. (1997) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1997.tb01664.x · Cited by 45
Steffen, T. (2001) · European Journal of Public Health · doi:10.1093/eurpub/11.4.425 · Cited by 45
Changes in HIV-1 Incidence in Heroin Users in Guangxi Province, China
Lai, S., Liu, W. Y., Chen, J., Yang, J., Li, Z.-J., Li, R., Liang, F.-X., Liang, S.-L., Zhu, Q.-Y., & Yu, X. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200104010-00014 · Cited by 44
Jones, L., Pickering, L., Sumnall, H. R., & McVeigh, J. (2008) · Cited by 43
Vickerman, P. T., Platt, L., Jolley, E., Rhodes, T., Kazatchkine, M. D., & Latypov, A. B. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.09.013 · Cited by 41
Self-citationAllen, E. J., Palmateer, N. E., Hutchinson, S. J., Cameron, S., Goldberg, D. J., & Taylor, A. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.07.006 · Cited by 40
Self-citationRuan, Y., Liang, S., Zhu, J., Li, X., Pan, S. W., Liu, Q., Song, B., Wang, Q., Xing, H. Q., & Shao, Y. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827fd4d4 · Cited by 36
Shi, J., Zhao, L., Epstein, D., Zhao, C.-Z., Shuai, Y., Yan, B., Jin, J., & Lu, L. (2007) · Journal of addiction medicine · doi:10.1097/adm.0b013e318156cc19 · Cited by 35
Falster, K., Kaldor, J. M., & Maher, L. (2008) · Journal of Urban Health · doi:10.1007/s11524-008-9330-7 · Cited by 35
Self-citationRisk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco
Tsui, J. I., Vittinghoff, E., Hahn, J. A., Evans, J. L., Davidson, P. J., & Page, K. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.022 · Cited by 34
Wand, H. C., Spiegelman, D. L., Law, M. G., Jalaludin, B. B., Kaldor, J. M., & Maher, L. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02704.x · Cited by 31
Self-citationZou, X., Ling, L., & Zhang, L. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008162 · Cited by 30
[Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima, A., Henrion, R., Lowenstein, W., & Charpak, Y. (2001) · PubMed · Cited by 30
Roy, É., Arruda, N., Leclerc, P., Haley, N., Bruneau, J., & Boivin, J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.05.018 · Cited by 29
Self-citationLong-Term Effects of Methadone Maintenance Treatment with Different Psychosocial Intervention Models
Wang, L., Wei, X., Wang, X., Li, J., Li, H., & Jia, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087931 · Cited by 27
Predictors of crack cocaine initiation among Montréal street youth: A first look at the phenomenon
Paquette, C., Roy, É., Petit, G., & Boivin, J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.010 · Cited by 26
Samo, R. N., Altaf, A., Agha, A., Pasha, O., Rozi, S., Memon, A. M., Azam, S., Blevins, M. L., Vermund, S. H., & Shah, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081715 · Cited by 26
Vorma, H., Sokero, P., Aaltonen, M., Turtiainen, S., Hughes, L. A., & Savolainen, J. (2013) · Addictive Behaviours · doi:10.1016/j.addbeh.2013.03.009 · Cited by 24
Todd, C. S., Nasir, A., Stanekzai, M. R., Fiekert, K., Sipsma, H. L., Vlahov, D., & Strathdee, S. A. (2015) · Harm Reduction Journal · doi:10.1186/s12954-015-0056-z · Cited by 23
Guadagnino, V., Zimatore, G. B., Izzi, A., Caroleo, B., Rocca, A., Montesano, F., Costa, C. C. P., Masciari, R., Naso, E., & Biselli, R. (1995) · PubMed · Cited by 21
Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
and the ANRS Methaville Study Group, Roux, P., Michel, L., Cohen, J., Mora, M., Morel, A., Aubertin, J.-F., Desenclos, J., Spire, B., & Carrieri, P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-488 · Cited by 20
Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users
Mikolajczyk, R., Horn, J., Prins, M., Wiessing, L. G., & Kretzschmar, M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.020 · Cited by 20
Solomon, S. S., Celentano, D. D., Srikrishnan, A. K., Vasudevan, C. K., Murugavel, K. G., Iqbal, H. S., Anand, S., Kumar, M., Latkin, C. A., Solomon, S. S., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq288 · Cited by 20
Risk Behaviors and HIV/AIDS Prevention Education Among IDUs in Drug Treatment in Shanghai
Zhao, M. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti110 · Cited by 20
Fatseas, M., Denis, C., Serre, F., Dubernet, J., Daulouède, J., & Auriacombe, M. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-0054-4 · Cited by 19
Hepatitis C treatment in drug users: perception versus evidence
Sylvestre, D. L. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200602000-00003 · Cited by 17
Bruandet, A., Lucidarme, D., Decoster, A., Ilèf, D., Harbonnier, J., Jacob, C., Delamare, C., Cyran, C., Hoenacker, A. F. V., Fremaux, D., et al. (2006) · PubMed · Cited by 17
O’Keefe, D., Scott, N., Aitken, C. K., & Dietze, P. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1668-z · Cited by 17
A Trial to Reduce Hepatitis C Seroincidence in Drug Users
Stein, M. D., Herman, D. S., & Anderson, B. J. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903183034 · Cited by 16
Intravenous opiate maintenance in a cohort of injecting drug addicts
Sendi, P., Hoffmann, M., Bucher, H. C., Erb, P., Haller, P., Gyr, N. E., & Battegay, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00316-2 · Cited by 16
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China
Zhou, W., Wang, X., Zhou, S., Xie, N., Liu, P., Luo, L., Peng, J., Liu, M., Desrosiers, A., Schottenfeld, R. S., et al. (2014) · Addiction · doi:10.1111/add.12836 · Cited by 14
Larney, S., Grebely, J., Falster, M., Swart, A., Amin, J., Degenhardt, L., Burns, L., & Vajdic, C. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.027 · Cited by 13
Self-citationNasir, A., Todd, C. S., Stanekzai, M. R., Bautista, C. T., Botros, B. A. M., Scott, P. T., Kim, J. H., Strathdee, S. A., & Tjaden, J. A. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.11.006 · Cited by 11
and the ANRS Methaville study group, Roux, P., Lions, C., Michel, L., Mora, M., Daulouède, J., Marcellin, F., Spire, B., Morel, A., & Carrieri, P. (2014) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-9-37 · Cited by 9
Javanbakht, M., Mirahmadizadeh, A., & Mashayekhi, A. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.13484 · Cited by 8
Evaluation of pilot methadone maintenance therapy in Georgia (Caucasus).
Gambashidze, N., Sikharulidze, Z., Piralishvili, G., & Gvakharia, N. (2008) · PubMed · Cited by 6
Residents and Patients: Telling Stories to Cope With Stress
Delwart, E. (1998) · JAMA · doi:10.1001/jama.280.22.1960 · Cited by 5
Clinical measurement of addictions
CLOUTIER, R., LESAGE, A. D., LANDRY, M., Kairouz, S., & Ménard, J.-M. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00278.x · Cited by 3
On the Impact of Community-based Methadone Maintenance Treatment Among Drug Addicts
Control, S. (2006) · Journal of Preventive Medicine Information · Cited by 2
Opiate substitution prescribing in Belfast – two year follow up study
Collins, R., Ewing, D., Boggs, B., Taggart, N., Drillingcourt, A., Kelly, M., & Patterson, D. (2009) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700000665 · Cited by 1
Cited by
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Self-citationPimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Self-citation
Metadata
- Authors
- Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., Bruneau, J., & Hickman, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-09-18
- Volume
- 2017
- Issue
- 9
- Pages
- CD012021-CD012021
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2754268575
- Cited by
- 305
- References
- 131
- FWCI
- 23.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.